Commentary Open Access
Volume 1 | Issue 4 | DOI: https://doi.org/10.33696/Signaling.1.024

Role of PI3K/Akt/GSK-3 Pathway in Emesis and Potential New Antiemetics

  • 1Department of Basic Medical Sciences, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences,309 East Second Street, Pomona, CA 91766, USA
+ Affiliations - Affiliations

Corresponding Author

Nissar A. Darmani, ndarmani@westernu.edu

Received Date: August 24, 2020

Accepted Date: September 18, 2020


Chemotherapy, Emesis, Ca2+, Emetic nuclei, PI3K, Akt, GSK-3

Author Information X